Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory EffectAtsuo Baba, Takashi Sohda, Yoshikazu Ohta et al.|Journal of Medicinal Chemistry|1996Cited by 151
Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603Yoshikazu Ohta, Haruhiko Makino, Atsuo Baba et al.|Immunopharmacology|1996Cited by 14
Studies on Disease-Modifying Antirheumatic Drugs. II. Synthesis and Activity of the Metabolites of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603).Atsuo Baba, Takashi Sohda, Haruhiko Makino et al.|Chemical and Pharmaceutical Bulletin|1998Cited by 6
Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603Yoshikazu Ohta, Haruhiko Makino, Shigeru Fukuda|Immunopharmacology|1997Cited by 1